Digital ulcers predict a worse disease course in patients with systemic sclerosis

被引:107
|
作者
Mihai, Carina [1 ]
Landewe, Robert [2 ,3 ]
van der Heijde, Desiree [4 ]
Walker, Ulrich A. [5 ]
Constantin, Paul I. [1 ]
Gherghe, Ana Maria [1 ]
Ionescu, Ruxandra [6 ]
Rednic, Simona [7 ]
Allanore, Yannick [8 ]
Avouac, Jerome [8 ]
Czirjak, Laszlo [9 ]
Hachulla, Eric [10 ]
Riemekasten, Gabriela [11 ]
Cozzi, Franco [12 ]
Airo, Paolo [13 ]
Cutolo, Maurizio [14 ,15 ]
Mueller-Ladner, Ulf [16 ]
Matucci-Cerinic, Marco [17 ,18 ]
机构
[1] Carol Davila Univ Med & Pharm, Dept Internal Med & Rheumatol, Cantacuzino Hosp, Ion Movila Str 5-7, Bucharest 020475, Romania
[2] Univ Amsterdam, Amsterdam Rheumatol Ctr, Heerlen, Netherlands
[3] Atrium Med Ctr, Heerlen, Netherlands
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
[5] Univ Basel Hosp, CH-4031 Basel, Switzerland
[6] Carol Davila Univ Med & Pharm, Dept Internal Med & Rheumatol, Sf Maria Hosp, Bucharest, Romania
[7] Iuliu Hatieganu Univ Med & Pharm, Rheumatol Clin, Cluj Napoca, Romania
[8] Paris Descartes Univ, Rheumatol Dept A, Cochin Hosp, Paris, France
[9] Univ Pecs, Dept Rheumatol & Immunol, Pecs, Hungary
[10] Claude Huriez Hosp, Dept Internal Med, Lille, France
[11] Charite, Dept Rheumatol, Berlin, Germany
[12] Univ Padua, Policlin, Dip Med Clin & Sperimentale, Cattedra Reumatol, Padua, Italy
[13] Spedali Civili Brescia, Rheumatol & Clin Immunol Serv, Brescia, Italy
[14] Univ Genoa, Res Lab, Genoa, Italy
[15] Univ Genoa, Acad Clin Unit Rheumatol, Genoa, Italy
[16] Univ Giessen, Dept Rheumatol & Clin Immunol, Bad Nauheim, Germany
[17] Univ Florence, Div Rheumatol AOUC, Florence, Italy
[18] Univ Florence, Dept Expt & Clin Med, Dept Biomed, Florence, Italy
关键词
EULAR SCLERODERMA TRIALS; ORGAN INVOLVEMENT; 5-YEAR SURVIVAL; RISK-FACTORS; COHORT; DATABASE; LESIONS; MODEL;
D O I
10.1136/annrheumdis-2014-205897
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Systemic sclerosis (SSc) is a systemic autoimmune disease with high morbidity and significant mortality. There is a great need of predictors that would allow risk stratification of patients with SSc and ultimately initiation of treatment early enough to ensure optimal clinical results. In this study, we evaluated whether a history of digital ulcers (HDU) at presentation may be a predictor of vascular outcomes and of overall clinical worsening and death in patients with SSc. Methods Patients from the EULAR Scleroderma Trials and Research (EUSTAR) database, satisfying at inclusion the 1980 American College of Rheumatology classification criteria for SSc, who had a follow-up of at least 3 years since baseline or who have died, were included in the analysis. HDU at presentation as a predictor of disease worsening or death was evaluated by Cox proportional hazards regression analysis. Results 3196 patients matched the inclusion criteria (male sex 13.2%, 33.4% diffuse subset). At presentation, 1092/3196 patients had an HDU (34.1%). In multivariable analysis adjusting for age, gender and all parameters considered potentially significant, HDU was predictive for the presence of active digital ulcers (DUs) at prospective visits (HR (95% CI)): 2.41 (1.91 to 3.03), p < 0.001, for an elevated systolic pulmonary arterial pressure on heart ultrasound (US-PAPs): 1.36 (1.03 to 1.80), p = 0.032, for any cardiovascular event (new DUs, elevated US-PAPs or LV failure): 3.56 (2.26 to 5.62), p < 0.001, and for death (1.53 (1.16 to 2.02), p = 0.003). Conclusions In patients with SSc, HDU at presentation predicts the occurrence of DUs at follow-up and is associated with cardiovascular worsening and decreased survival.
引用
收藏
页码:681 / 686
页数:6
相关论文
共 50 条
  • [1] Angiogenic Biomarkers Predict the Development of Digital Ulcers in Patients with Systemic Sclerosis
    Avouac, Jerome
    Meune, Christophe
    Kahan, Andre
    Chiocchia, Gilles
    Allanore, Yannick
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S586 - S586
  • [2] Digital ulcers in patients with systemic sclerosis
    Chung, L
    Fiorentino, D
    [J]. AUTOIMMUNITY REVIEWS, 2006, 5 (02) : 125 - 128
  • [3] Bosentan for digital ulcers in patients with systemic sclerosis
    Nagai, Yayoi
    Hasegawa, Michiko
    Hattori, Tomoyasu
    Okada, Etsuko
    Tago, Osamu
    Ishikawa, Osamu
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (01): : 48 - 51
  • [4] Pathophysiology of digital ulcers in patients with systemic sclerosis
    Giuggioli, D.
    Colaci, M.
    Manfredi, A.
    Sebastiani, M.
    Ferri, C.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 : 73 - 73
  • [5] Management of digital ulcers in patients with systemic sclerosis
    Riemekasten, G.
    Hoffmann, U.
    Sunderkoetter, C.
    Weiss, N.
    Kuhn, A.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (1-2) : 34 - 40
  • [6] Bosentan for digital ulcers in patients with systemic sclerosis
    Nagai, Yayoi
    Hasegawa, Michiko
    Tago, Osamu
    Ishikawa, Osamu
    [J]. JOURNAL OF DERMATOLOGY, 2010, 37 : 68 - 68
  • [7] Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis
    Avouac, Jerome
    Meune, Christophe
    Ruiz, Barbara
    Couraud, Pierre Olivier
    Uzan, Georges
    Boileau, Catherine
    Kahan, Andre
    Chiocchia, Gilles
    Allanore, Yannick
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) : 394 - 399
  • [8] ANGIOGENIC BIOMARKERS PREDICT THE OCCURRENCE OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS
    Avouac, J.
    Meune, C.
    Kahan, A.
    Chiocchia, G.
    Allanore, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 116 - 116
  • [9] Digital ulcers: overt vascular disease in systemic sclerosis
    Steen, V.
    Denton, C. P.
    Pope, J. E.
    Matucci-Cerinic, M.
    [J]. RHEUMATOLOGY, 2009, 48 : 19 - 24
  • [10] Digital ulcers in systemic sclerosis
    Hughes, Michael
    Herrick, Ariane L.
    [J]. RHEUMATOLOGY, 2017, 56 (01) : 14 - 25